Endocannabinoid System & Chronic Low Back Pain: Phase 3 Trial Results on Cannabis Sativa Extracts
Comments Off on Endocannabinoid System & Chronic Low Back Pain: Phase 3 Trial Results on Cannabis Sativa Extracts
May 5, 2026
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with extended follow-up reaching 15 months. The trial used a…
Cannabis Sativa Extracts for Chronic Low Back Pain: A Phase 3 Randomized Trial
Comments Off on Cannabis Sativa Extracts for Chronic Low Back Pain: A Phase 3 Randomized Trial
May 4, 2026
Clinical Takeaway A phase 3 randomized controlled trial enrolled 820 adults with chronic low back pain to evaluate VER-01, a full-spectrum cannabis extract, against placebo over a 12-week double-blind period with up to one year of follow-up. The trial…
endocannabinoid system clinical research: Cannabis for Back Pain
Comments Off on endocannabinoid system clinical research: Cannabis for Back Pain
April 15, 2026
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with longer-term follow-up extending to one year. This…